THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Genzyme rebuffs Sanofi yet again

Offer overlooks cuts, changes, board says

By Robert Weisman
Globe Staff / October 8, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Genzyme Corp.’s board has unanimously turned thumbs down on the $69-a-share hostile tender offer launched Monday by drug maker Sanofi Aventis SA and formally recommended that Genzyme stockholders don’t hand over their shares to the French suitor. (Full article: 447 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass